Novel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels

Microvascular Research

Volumn 86, Issue 1, 2013, Pages 1-10

  Paul, Debayon ^a   Cowan, Ann E ^a   Ge, Shujun ^a   Pachter, Joel S ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 5; TIGHT JUNCTION PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CAPILLARY; CELL DENSITY; CELL HETEROGENEITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; IMAGE ANALYSIS; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LAMINECTOMY; MICROVASCULAR ENDOTHELIAL CELL; MICROVASCULATURE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; THORACOLUMBAR SPINE; THREE DIMENSIONAL IMAGING; TIGHT JUNCTION; VENULE;

ANIMALS; BLOOD-BRAIN BARRIER; CAPILLARIES; CAPILLARY PERMEABILITY; CLAUDIN-5; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; FEMALE; IMAGING, THREE-DIMENSIONAL; IMMUNOGLOBULIN G; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MICROVESSELS; MULTIPLE SCLEROSIS; SPINAL CORD; TIGHT JUNCTIONS; VENULES;

ANIMALIA; MUS;

EID: 84873709408     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2012.12.001     Document Type: Article

References (76)

1. Abbott N.J., et al. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 2006, 7:41-53.
2. Alvarez J.I., Teale J.M. Evidence for differential changes of junctional complex proteins in murine neurocysticercosis dependent upon CNS vasculature. Brain Res. 2007, 1169:98-111.
3. Argaw A.T., et al. VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:1977-1982.
4. Bake S., et al. Reproductive age-related changes in the blood-brain barrier: expression of IgG and tight junction proteins. Microvasc. Res. 2009, 78:413-424.
5. Batoulis H., et al. Experimental autoimmune encephalomyelitis-achievements and prospective advances. APMIS 2011, 119:819-830.
6. Bechmann I., et al. What is the blood-brain barrier (not)?. Trends Immunol. 2007, 28:5-11.
7. Bennett J., et al. Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE. J. Neuroimmunol. 2010, 229:180-191.
8. Bergman C.M. A switch in pathogenic mechanism in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in IFN-μ-inducible thiol reductase-free mice. J. Immunol. 2012, 188:6001-6009.
9. Berne R.M., Levy M.N. The circuitry. Physiology 1988, 395-397. C.V. Mosby Co.
10. Blasig I.E., Haseloff R.F. Tight junctions and tissue barriers. Antioxid. Redox Signal. 2011, 15:1163-1166.
11. Brown A., Sawchenko P.E. Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis. J. Comp. Neurol. 2007, 502:236-260.
12. Calabria A.R., et al. Puromycin-purified rat brain microvascular endothelial cell cultures exhibit improved barrier properties in repsonse to glucocorticoid induction. J. Neurochem. 2006, 97:922-933.
13. Carvey P.M., et al. The blood-brain barrier in neurodegenerative disease: a rhetorical perspective. J. Neurochem. 2009, 111:291-314.
14. Cavaglia M., et al. Regional variation in brain capillary density and vascular response to ischemia. Brain Res. 2001, 910:81-93.
15. Claudio L., et al. Increased vesicular transport and decreased mitochondrial content in blood-brain barrier endothelial cells during experimental autoimmune encephalomyelitis. Am. J. Pathol. 1989, 135:1157-1168.
16. Coisne C., Engelhardt B. Tight junctions in brain barriers during central nervous system inflammation. Antioxid. Redox Signal. 2011, 15:1285-1303.
17. Dobrogowska D.H., Vorbrodt A.W. Immunogold localization of tight junctional proteins in normal and osmotically-affected rat blood-brain barrier. J. Mol. Histol. 2004, 35:529-538.
18. Engelhardt B., Sorokin L. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin. Immunopathol. 2009, 31:497-511.
19. Errede M., et al. Blood-brain barrier alterations in the cerebral cortex in experimental autoimmune encephalomyelitis. J. Neuropathol. Exp. Neurol. 2012, 71:840-854.
20. Fawcett D.W. Bloom and Fawcett A Textbool of Histology 1994, Chapman and Hall, New York. twelfth ed.
21. 2 induces paracellular permeability of porcine brain-derived microvascular endothelial cells by activation of the p44/42 MAP kinase pathway. Eur. J. Cell Biol. 2005, 84:687-697.
22. Furuse M. Molecular basis of the core structure of tight junctions. Cold Spring Harb. Perspect. Biol. 2010, 2:a002907.
23. Garrido-Urbani S., et al. Vascular and epithelial junctions: a barrier for leucocyte migration. Biochem. Soc. Trans. 2008, 36:203-211.
24. Ge S., et al. Where is the blood-brain barrier really?. J. Neurosci. Res. 2005, 79:421-427.
25. Gesuete R., et al. Glial cells drive precondtioning-induced blood-brain barrier protection. Stroke 2011, 42:1445-1453.
26. Gidday J.M., et al. Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H558-H568.
27. Grammas P., et al. Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases. Expert Rev. Mol. Med. 2011, 13:e19.
28. Gruppe T.L., et al. The extent of ultrastructural spinal cord pathology reflects disease severity in experimental autoimmune encephalomyelitis. Histol. Histopathol. 2012, 27:1163-1174.
29. Haorah J., et al. Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise. Alcohol. Clin. Exp. Res. 2005, 29:999-1009.
30. Hawkins B.T., Davis T.P. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 2005, 57:173-185.
31. Ishizaki T., et al. Cyclic AMP induces phosphorylation of claudin-5 immunoprecipitates and expression of claudin-5 gene in blood-brain-barrier endothelial cells via protein kinase A-dependent and -independent pathways. Exp. Cell Res. 2003, 290:275-288.
32. Ivey N.S., et al. Association of FAK activation with lentivirus-induced disruption of blood-brain barrier tight junction-associated ZO-1 protein organization. J. Neurovirol. 2009, 15:312-323.
33. Jalali S., et al. Focused ultrasound-mediated BBB disruption is associated with an increase in activation of AKT: experimental study in rats. BMC Neurol. 2010, 10:114.
34. Janacek J., et al. A novel method for evaluation of capillarity in human skeletal muscles from confocal 3D images. Microvasc. Res. 2011, 81:231-238.
35. Kreuter J. Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB). J Microencapsul. 2013, 30:49-54.
36. Leeson R.C., et al. Text/Atlas of Histology 1988, W.B. Saunders Company, Philadelphia.
37. Liebner S., et al. Current concepts of blood-brain barrier development. Int. J. Dev. Biol. 2011, 55:467-476.
38. Luissint A.C., et al. Guanine nucleotide-binding protein Gαi2: a new partner of claudin-5 that regulates tight junction integrity in human brain endothelial cells. J. Cereb. Blood Metab. 2012, 32:860-873.
39. Ma T., et al. Evidence for involvement of ROCK signaling in bradykinin-induced increase in murine blood-tumor barrier permeability. J. Neurooncol. 2012, 106:291-301.
40. Macdonald J.A., et al. Endothelial cell heterogeneity of blood-brain barrier gene expression along the cerebral microvasculature. J. Neurosci. Res. 2010, 88:1457-1474.
41. Mix E., et al. Animal models of multiple sclerosis-potentials and limitations. Prog. Neurobiol. 2010, 92:386-404.
42. Morgan L., et al. Inflammation and dephosphorylation of the tight junction protein occludin in an experimental model of multiple sclerosis. Neuroscience 2007, 147:664-673.
43. Morin-Brureau M., et al. Epileptiform activity induces vascular remodeling and zonula occludens 1 downregulation in organotypic hippocampal cultures: role of VEGF signaling pathways. J. Neurosci. 2011, 31:10677-10688.
44. Morita K., et al. Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J. Cell Biol. 1999, 147:185-194.
45. Moxon-Emre I., Schlichter L.C. Neutrophil depletion reduces blood-brain barrier breakdown, axon injury, and inflammation after intracerebral hemorrhage. J. Neuropathol. Exp. Neurol. 2011, 70:218-235.
46. Murugesan N., et al. Active induction of experimental autoimmune encephalomyelitis by MOG35-55 peptide immunization is associated with differential responses in separate compartments of the choroid plexus. Fluids Barriers CNS 2012, 9:15.
47. Nagy Z., et al. Fracture faces of cell junctions in cerebral endothelium during normal and hyperosmotic conditions. Lab. Invest. 1984, 50:313-322.
48. Nakagawa S., et al. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem. Int. 2009, 54:253-263.
49. Nitta T., et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 2003, 161:653-660.
50. Ohtsuki S., et al. Exogenous expression of claudin-5 induces barrier properties in cultured rat brain capillary endothelial cells. J. Cell. Physiol. 2007, 210:81-86.
51. Owens T., et al. Perivascular spaces and the two steps to neuroinflammation. J. Neuropathol. Exp. Neurol. 2008, 67:1113-1121.
52. Pachner A.R. Experimental models of multiple sclerosis. Curr. Opin. Neurol. 2011, 24:291-299.
53. Paolinelli R., et al. The molecular basis of the blood-brain barrier differentiation and maintenance. Is it still a mystery?. Pharmacol. Res. 2011, 63:165-171.
54. Persidsky Y., et al. Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE). Blood 2006, 107:4770-4780.
55. Petty M.A., Lo E.H. Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation. Prog. Neurobiol. 2002, 68:311-323.
56. Pfeiffer F., et al. Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental auotimmune encephalomyelitis. Acta Neuropathol. 2011, 122:601-614.
57. Pober J.S., Sessa W.C. Evolving functions of endothelial cells in inflammation. Nat. Rev. Immunol. 2007, 7:803-815.
58. Proulx D.P., et al. Interaction between intravenous immunoglobulin (IVIg) and the low-density lipoprotein receptor-related protein 1: a role for transcytosis across the blood brain barrier?. J. Neuroimmunol. 2012, 251:39-44.
59. Pun P.B., et al. Involvement of ROS in BBB dysfunction. Free Radic. Res. 2009, 43:348-364.
60. Ross M.H., Pawlina W. Histology: A Text and Atlas 2006, Lippincott Williams and Wilkins, Baltimore. fifth ed.
61. Saubamea B., et al. Heterogeneity in the rat brain vasculature revealed by quantitative confocal analysis of endothelial barrier antigen and P-glycoprotein expression. J. Cereb. Blood Flow Metab. 2012, 32:81-92.
62. Sheikov N., et al. Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium. Ultrasound Med. Biol. 2008, 34:1093-1104.
63. Simionescu N., Simionescu M. The cardiovascular system. Histology 1977, 373-431. McGraw Hill, New York. L. Weiss, R.O. Greep (Eds.).
64. Sixt M., et al. Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis. J. Cell Biol. 2001, 153:933-946.
65. Song L., Pachter J.S. Culture of murine brain microvascular endothelial cells that maintain expression and cytoskeletal association of tight junction-associated proteins. In Vitro Cell Dev. Biol. Anim. 2003, 39:313-320.
66. Song L., Pachter J.S. Monocyte chemoattractant protein-1 alters expression of tight junction-associated proteins in brain microvascular endothelial cells. Microvasc. Res. 2004, 67:78-89.
67. Suen W.E., et al. A critical role for lymphotoxin in experimental allergic encephalomyelitis. J. Exp. Med. 1997, 189:1233-1240.
68. Suidan G.L., et al. Induction of blood brain barrier tight junction protein alterations by CD8 T cells. PLoS One 2008, 3:e3037.
69. Thurston G., et al. Determinants of endothelial cell phenotype in venules. Microcirculation 2000, 7:67-80.
70. van Horssen J., et al. Basement membrane proteins in multiple sclerosis-associated inflammatory cuffs: potential role in influx and transport of leukocytes. J. Neuropathol. Exp. Neurol. 2005, 64:722-729.
71. Vorbrodt A.W., et al. Ultrastructural localization of lectin receptors on the luminal and abluminal aspects of brain micro-blood vessels. J. Histochem. Cytochem. 1986, 34:251-261.
72. Ward R., et al. A quantitative study of cerebrovascular variation in inbred mice. J. Anat. 1990, 173:87-95.
73. Wolburg H., et al. Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Acta Neuropathol. 2003, 105:586-592.
74. Xu H., Liversidge J. Quantitative in situ analysis of claudin expression at the blood-retinal barrier. Methods Mol. Biol. 2011, 762:321-331.
75. Xu H., et al. Leukocyte diapedesis in vivo induces transient loss of tight junction protein at the blood-retina barrier. Invest. Ophthalmol. Vis. Sci. 2005, 46:2487-2494.
76. Zhong Y., et al. Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling. J. Neurosci. 2008, 28:7788-7796.